Aqueous and ethanolic extracts of Moringa oleifera leaves induce selective cytotoxicity in Raji and Jurkat cell lines by activating the P21 pathway independent of P53
- PMID: 39760794
- DOI: 10.1007/s11033-024-10200-9
Aqueous and ethanolic extracts of Moringa oleifera leaves induce selective cytotoxicity in Raji and Jurkat cell lines by activating the P21 pathway independent of P53
Abstract
Background: The traditional use of Moringa oleifera (MO), an essential food source in Africa and Asia, to cure various diseases dates back thousands of years. This study examines the aqueous and ethanolic leaf extracts of MO's in vitro anti-leukemia capabilities.
Methods: After preparing aqueous and ethanolic MO leaf extracts, cells were treated with various concentrations for 48 h. Cell viability was measured via MTT assay, and apoptotic pathways were analyzed using flow cytometry and Annexin V-PI staining. Following RNA extraction and cDNA synthesis, cells were exposed to the IC50 (150 µg/ml) for 48 h. Real-time PCR assessed the expression of P21, P53, BCL2, and Survivin genes. Peripheral blood mononuclear cells (PBMCs) served as the control group.
Results: MO aqueous and ethanol extracts showed cytotoxicity, with cancer cells being more sensitive. Flow cytometry confirmed higher apoptotic activity in Jurkat and Raji cells compared to PBMCs. The extracts increased P21 expression in Jurkat cells but did not significantly affect P53, BCL2, or Survivin. Similarly, in Raji cells, P21, BCL2, and Survivin were elevated, while P53 remained unchanged. Gene expression in healthy PBMCs was unaffected by the extracts.
Conclusion: This study shows that leukemia cells (Raji and Jurkat) are more sensitive to MO's aqueous and ethanolic extracts than healthy cells. The results suggest developing MO extracts as a cutting-edge leukemia treatment.
Keywords: Apoptosis; Jurkat cells; Leukemia; Moringa oleifera; Raji cells.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Ethical approval: The Bushehr University of Medical Sciences’ ethics committee has given its approval for this work. The (IR.BPUMS.REC.1398.156) is the reference number. Consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Dichloromethane fraction of Moringa oleifera leaf methanolic extract selectively inhibits breast cancer cells (MCF7) by induction of apoptosis via upregulation of Bax, p53 and caspase 8 expressions.Mol Biol Rep. 2021 May;48(5):4465-4475. doi: 10.1007/s11033-021-06466-y. Epub 2021 Jun 4. Mol Biol Rep. 2021. PMID: 34086162
-
Moringa oleifera's Nutritious Aqueous Leaf Extract Has Anticancerous Effects by Compromising Mitochondrial Viability in an ROS-Dependent Manner.J Am Coll Nutr. 2016 Sep-Oct;35(7):604-613. doi: 10.1080/07315724.2015.1080128. Epub 2016 Jun 17. J Am Coll Nutr. 2016. PMID: 27314649
-
Moringa oleifera leaves protein suppresses T-lymphoblastic leukemogenesis via MAPK/AKT signaling modulation of apoptotic activation and autophagic flux regulation.Front Immunol. 2025 Apr 1;16:1546189. doi: 10.3389/fimmu.2025.1546189. eCollection 2025. Front Immunol. 2025. PMID: 40236708 Free PMC article.
-
The effects of Moringa oleifera on blood glucose levels: A scoping review of the literature.Complement Ther Med. 2020 May;50:102362. doi: 10.1016/j.ctim.2020.102362. Epub 2020 Feb 28. Complement Ther Med. 2020. PMID: 32444043
-
Moringa oleifera in a modern time: A comprehensive review of its nutritional and bioactive composition as a natural solution for managing diabetes mellitus by reducing oxidative stress and inflammation.Food Res Int. 2025 Feb;201:115671. doi: 10.1016/j.foodres.2025.115671. Epub 2025 Jan 4. Food Res Int. 2025. PMID: 39849793 Review.
Cited by
-
Exploring the Functional Properties of Leaves of Moringa oleifera Lam. Cultivated in Sicily Using Precision Agriculture Technologies for Potential Use as a Food Ingredient.Antioxidants (Basel). 2025 Jun 27;14(7):799. doi: 10.3390/antiox14070799. Antioxidants (Basel). 2025. PMID: 40722903 Free PMC article.
-
CDH3 promotes the progression of lung adenocarcinoma through driving epithelial-mesenchymal transition progress.J Transl Med. 2025 Aug 8;23(1):887. doi: 10.1186/s12967-025-06750-6. J Transl Med. 2025. PMID: 40781712 Free PMC article.
-
Engineered macrophage membrane-coated dihydroartemisinin nanoparticles with enhanced CCR2 expression improved symptoms in MRL/LPR mice by metabolic reprogramming of proinflammatory macrophages.J Transl Med. 2025 Jun 2;23(1):608. doi: 10.1186/s12967-025-06574-4. J Transl Med. 2025. PMID: 40457421 Free PMC article.
-
Targeting platelet-tumor cell interactions: a novel approach to cancer therapy.Med Oncol. 2025 Jun 2;42(7):232. doi: 10.1007/s12032-025-02787-1. Med Oncol. 2025. PMID: 40457079 Review.
-
Dynamic evolution and antitumor mechanisms of CXCR6+CD8+ T cells in small cell lung cancer treated with low-dose radiotherapy and immunotherapy.J Transl Med. 2025 Apr 17;23(1):453. doi: 10.1186/s12967-025-06450-1. J Transl Med. 2025. PMID: 40247265 Free PMC article.
References
-
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 74(3):229–263 - DOI
-
- Aghapour SA, Torabizadeh M, Bahreiny SS, Saki N, Jalali Far MA, Yousefi-Avarvand A et al (2024) Investigating the dynamic interplay between Cellular Immunity and Tumor cells in the Fight Against Cancer: an updated Comprehensive Review. IJBC 16(2):84–101
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous